baber/WOPTO huggingface dataset:
Patent NZ-219054-A (NZ)
Title: Making ceramic composite articles by inverse shape replication
Inventor: NEWKIRK MARC STEVENS
IPC: C04B35/65
Filed: 1987-01-26
Abstract: A method of producing a self-supporting ceramic composite body having therein at least one cavity which inversely replicates the geometry of a positive mold of parent metal, includes embedding the mold of parent metal within a conformable bed of filler to provide therein a cavity shaped and filled by the mold. The assembly is heated to melt the parent metal mold, e.g., an aluminum parent metal mold, and contacted with an oxidant to oxidize the molten parent metal to form a polycrystalline material which grows through the surroundings of filler, the molten metal being drawn through the growing polycrystalline material to be oxidized at the interface between the oxidant and previously formed oxidation reaction product whereby the cavity formerly filled by the mold of parent metal is eventually evacuated by the metal. There remains behind a cavity whose shape inversely replicates the original shape of the mold. The method provides ceramic composite articles having therein at least one cavity inversely replicating the shape of the mold which supplied the parent metal for oxidation.
Patent NZ-225660-A (NZ)
Title: Individual optical isomers of 2-methylspiro-(1,3-oxathiolan-5,3')-quinuclidine, and pharmaceutical compositions containing such
Inventor: FISHER ABRAHAM
IPC: A61P25/28
Filed: 1988-08-02
Abstract: The (+)-cis-, (-)-cis-, (+)-trans- and (-)-trans- forms of 2-methylspiro(1,3-oxathiolan-5,3 min )quinuclidine <CHEM> are prepared by optical resolution of each of the (+/-)-cis- and (+/-)-trans-isomers. These compounds find application in treating diseases of the central nervous system in mammals, especially diseases due to a deficiency in the central cholinergic system. Biological tests indicate that the (-)-cis-form, as well as the (+/-)-cis-isomer, shows particular promise for treating senile dementia of Alzheimer's type.
Patent NZ-229118-A (NZ)
Title: 6,8a-deepoxy-6,8a-dihydroxy avermectin derivatives; pharmaceutical and pesticidal compositions
Inventor: FISHER MICHAEL H
IPC: A61P31/04
Filed: 1989-05-15
Abstract: There are disclosed novel avermectin compounds having a cleaved furan ring and a hydroxy group in the 8a position. Processes for preparing these novel compounds are also disclosed. These compounds have utility as anti-parasitic agents and as insecticides against agricultural pests.
Patent NZ-238539-A (NZ)
Title: Kaolin paper coating composition containing a defined and delaminated suspension of uncalcined kaolin clay
Inventor: BUNDY WAYNE MILEY
IPC: D21H17/68
Filed: 1991-06-13
Abstract: A defined and delaminated kaolin composition exhibiting high opacity is produced by defining and delaminating a base kaolin clay so as to reduce its colloidal content. The defined and delaminated kaolin composition may also be treated with hexamethylenediamine and aluminum sulfate to further enhance opacity. Whether treated or untreated, the defined and delaminated kaolin composition functions superiorly in paper coating formulations, alone or blended with known coating clays, improving the opacity, print gloss, sheet gloss and printability of paper sheet coated therewith.
Patent NZ-241041-A (NZ)
Title: Bisphosphonic acid derivatives and pharmaceutical compositions
Inventor: NIKANDER HANNU
IPC: C07F9/576
Filed: 1991-12-18
Abstract: Bisphosphonic acid derivs. of formula (I) and their geometrical, optically active isomers and salts are new. In (I), R1, R2, R3 and R4 = opt. branched, opt. unsatd. 1-10C alkyl, opt. unsatd. 3-10C cycloalkyl, aryl, aralkyl, silyl, SiR3 or H, where at least one or R1, R2, R3 and R4 is H, and at least one is not H; Q1 = H, OH, halo, NH2 or OR1; R1 = 1-4C lower alkyl or acyl; Q2 = opt. branched, opt. unsatd. 1-10C alkyl, hydroxyalkyl, aminoalkyl where the O is opt. substd. by one gp.; and N is opt. substd. by 2 gps. from 1-4C lower alkyl or acyl or two gp. on N form opt. saturated or aromatic heterocylic ring or Q2 is opt. substd., opt. partially unsatd. 3-10C cycloalkyl, opt. bonded to opt. branched 1-4C alkylene gp. Specifically claimed are 21 cpds. including (1-hydroxyethylidene) bisphosphonic acid monomethyl (Ia) and monoethyl ester.
Patent NZ-273647-A (NZ)
Title: Freezing frame for blood bags, has two cylindrically curved perforated plates that contain a freezing bag during a freezing process
Inventor: BELL SUSAN HELEN
IPC: A61M1/02
Filed: 1994-09-27
Abstract: A freezing frame (39) has two cylindrically curved perforated plats (40, 41) adapted to contain a freezing bag (10) during a freezing process in which the bag is suspended with its length vertical in a freezing medium, including, on each plate (40, 41), a series of horizontally disposed ribs (48) extending into the volume of the frame.
Patent NZ-295352-A (NZ)
Title: Use of binding agents like antibodies for inhibiting cd23 in treating prophylaxis of autoimmune diseases
Inventor: BONNEFOY JEAN-YVES MARCEL PAUL
IPC: A61P31/04
Filed: 1995-10-20
Abstract: Binding agents to CD23 can be useful in the treatment of inflammatory, autoimmune or allergic diseases.
Patent NZ-296534-A (NZ)
Title: Preparation of halomethylbenzoyl cyanides
Inventor: ISAK HEINZ
IPC: C07C253/14
Filed: 1995-11-14
Abstract: PCT No. PCT/EP95/04463 Sec. 371 Date May 6, 1997 Sec. 102(e) Date May 6, 1997 PCT Filed Nov. 14, 1995 PCT Pub. No. WO96/16023 PCT Pub. Date May 30, 1996Halomethylbenzoyl cyanides I PH-CO-CN (I) where Ph is phenyl which is substituted by chloromethyl or bromomethyl and may cary 1-4 other rradicals, are prepared from halomethylbenzoyl chlorides II PH-CO-Cl (II), by reacting II with a cyanide-donating compound in the presence of a Lewis acid, if required in an inert organic solvent or diluent, and then isolating the product. The halomethylbenzoyl cyanides I are important intermediates for synthesizing crop protection agents.
Patent NZ-305361-A (NZ)
Title: Process for preparing anhydroecgonine esters
Inventor: MOLDT PETER
IPC: C07D451/02
Filed: 1996-03-22
Abstract: PCT No. PCT/EP96/01277 Sec. 371 Date Nov. 4, 1997 Sec. 102(e) Date Nov. 4, 1997 PCT Filed Mar. 22, 1996 PCT Pub. No. WO96/30371 PCT Pub. Date Oct. 3, 1996The present invention discloses compounds of the formula any mixture thereof, or a pharmaceutically acceptable salt thereof; wherein R, R3, and R4 each have the meanings set forth in the specification. The compounds possess valuable pharmaceutical properties as dopamine reuptake inhibitors.
Patent NZ-311145-A (NZ)
Title: Controlled release formulations containing a poorly soluble drug in a solid dispersion with a hydrophilic poloxamer
Inventor: CLANCY MARUICE JOSEPH ANTHONY
IPC: A61K47/34
Filed: 1996-07-01
Abstract: A controlled release formulation for oral administration comprises a solid dispersion of a poorly soluble active ingredient in a hydrophilic poloxamer, the solid dispersion being a component of a core and the core as such or following coating of the core with a polymeric coating being effective to achieve therapeutic levels of the active ingredient over extended periods of time (24 hours or longer) following oral administration. The formulation can be in a multi-particulate form such as pellets or mini-tablets or in the form of tablets. Examples of active ingredients whose solubility and therapeutic effectiveness can be improved with the formulation are cisapride, cyclosporin, diclofenac, felodipine, ibuprofen, indomethacin, nicardipine, nifedipine, terfenadine and theophylline.
Patent NZ-328490-A (NZ)
Title: Roadside marker post comprising a central portion and two tapered wings
Inventor: AKERS KENNETH SIDNEY
IPC: E01F9/011
Filed: 1998-10-29
Abstract: The extruded plastics body of a roadside marker post comprises a centre portion 3 and two tapered wings 1.  The wings may be curved and the centre portion may have at least one substantially flat surface.  The marker may be provided with longitudinal guide ribs 2 at the edges of the centre portion.
Patent NZ-333250-A (NZ)
Title: Helicobacter pylori blood group antigen binding adhesion protein
Inventor: BOREN THOMAS
IPC: C12P21/08
Filed: 1997-06-10
Abstract: The Helicobacter pylori blood group antigen binding (BAB) adhesion protein was isolated and purified, whereby said protein or fractions thereof bind specifically to fucosylated blood group antigens. The protein sequence of the adhesion and the isolated DNA for expressing the protein are defined in the specification. A pharmaceutical composition thereof is useful in the treatment and/or prevention of gastrointestinal diseases, caused by Helicobacter pylori or other Helicobacter.
Patent NZ-334455-A (NZ)
Title: Cleaning lance has two adjacent barrels with a mesh and sliding valve member
Inventor: KIRK COLIN JOHN
IPC: B05B1/16
Filed: 1997-09-04
Abstract: A cleaning lance is provided in which water from an inlet (1) is directed either to an upper, rinsing barrel (5) or to a lower, foamer barrel (12) and a coupling (8) is arranged to support a detergent container (9) below both barrels.  Foamer barrel (12) is provided with a mixing chamber (19) having an inlet for detergent supplied via a flow control valve (2).  A water jet injected into the mixing chamber via a Venturi nozzle (3) draws in and mixes with the detergent and the resulting mixture is ejected by a further Venturi nozzle (4) and draws in air from an exterior air inlet (20) to form a jet of cleaning foam.  A mesh (13) is located in second barrel (12) downstream of mixing chamber (19) for foam the mixture.  First and second barrels (5, 12) are coupled by latching valve means (15) to a common water inlet (10.  Valve means (15) has a default position in which valve means (15) selectively couples first barrel (5) to water inlet (1) and is operable by a user on reducing water pressure at the water inlet.  Valve means (15) comprises a rolling or sliding valve member (14) which is moveable to selectively block one of a lower inlet (18) to second barrel (12) and an upper inlet (17) to first barrel (5).  Valve means (15) defines a curved path for sliding valve member (14) as it moves in use between its selective blocking positions.
Patent NZ-507995-A (NZ)
Title: Controlling maximum speed of an internal combustion engine, typically driving pump for firefighting, by determining if electrical signal is within frequency window
Inventor: BORKOWSKI ANDRZEJ
IPC: F04B49/10
Filed: 2000-11-06
Abstract: An apparatus is disclosed for automatic shut-off of a combustion engine driving a fluid pump of a fluid displacement unit. The fluid displacement unit is protected from damage due to high running speeds by shutting off the combustion engine and by automatically resetting the combustion engine for manual restart subsequent to the combustion engine spinning down to a rest.
Patent NZ-512514-A (NZ)
Title: Method of forming vehicle interior resonant panel-form loudspeakers by obtaining standard deviation of mechanical impedance as frequency is varied
Inventor: AZIMA HENRY
IPC: H04R1/02
Filed: 2000-01-27
Abstract: A method of making a vehicle interior trim panel having at least one integral resonant bending wave loudspeaker panel, comprising designing the trim panel to comprise at least one panel area capable of and intended to operate as a resonant bending wave loudspeaker, making a prototype trim panel to the design, optimising at least one parameter of the prototype panel as concerns its behaviour as a resonant bending wave loudspeaker by obtaining the standard deviation, as frequency is varied, of the mechanical impedance of the panel as a function of the at least one parameter, selecting a value or values of said at least one parameter that result in a minimum of said standard deviation of the mechanical impedance of the panel, and making a trim panel in which the at least one parameter to be optimised has the selected value or values.
Patent NZ-514802-A (NZ)
Title: Saddle girth in the shape of a chevron for greater saddle stability and equine comfort
Inventor: SWAIN BARRIE P
IPC: B68C1/14
Filed: 2001-10-15
Abstract: A cinch or girth for a horse saddle, which has a central portion and two opposing straight segments, is described.  Each opposing straight segment extends away from the central portion of the girth band at an angle to form a chevron.  Alternatively, the girth may be in the shape of a true chevron, with the two straight segments coming substantially to a point at the central portion.  The total length of the girth is determined by the size and shape of the horse.
Patent NZ-517548-A (NZ)
Title: Non-bioluminescent Anthozoa derived chromophores / fluorophores and methods for using the same
Inventor: LUKYANOV SERGEY ANATOLIEVICH
IPC: C12Q1/25
Filed: 2000-10-13
Abstract: Anthozoa derived chromo/fluoroproteins and mutants thereof, as well as nucleic acid compositions encoding the same, are provided. Specific proteins of interest include chromo/fluoroproteins from the following specific anthozoa species: Anemonia majano, Clavularia sp., Zoanthus sp., Zoanthus sp., Discosoma striata, Discosoma sp. "red", Anemonia sulcata, Discosoma sp. "green", Discosoma sp. "magenta", and mutants thereof. Also provided are fragments of the subject proteins and nucleic acids encoding the same, as well as antibodies to the subject proteins and transgenic cells and organisms. The subject protein and nucleic acid compositions find use in a variety of different applications. Finally, kits for use in such applications that include the subject proteins are provided.
Patent NZ-518222-A (NZ)
Title: Use of strains of streptococcus thermophilus which are incapable of hydrolyzing urea in dairy products
Inventor: SEPULCHRE ANNE-MARIE
IPC: A23C19/032
Filed: 2000-09-15
Abstract: The use of at least one strain of Streptococcus thermophilus which is totally incapable of hydrolyzing urea, during the manufacture of cheeses of fermented dairy products such as yoghurt, in order to obtain an acidification kinetic which is substantially independent of the content of the milk in terms of its constituents; a method for obtaining, during the manufacture of cheeses or fermented dairy products, an acidification kinetic which is substantially independent of the content of the milk in terms of its constituents, in which there is incorporated with the milk at least one strain of Streptococcus thermophilus whish is totally incapable of hydrolyzing urea; and a method of selecting Streptococcus thermophilus strains useful during the manufacture of chesses of fermented dairy products.
Patent NZ-521340-A (NZ)
Title: Steam cap, with inner and outer cap, relief valve within inner cap, and pressure indicator
Inventor: WILLIAMS STEVEN
IPC: A47J27/09
Filed: 2002-09-12
Abstract: The steam cap is intended to be applied to steam vessels used in electrical domestic appliances, and consists of an outer cap 2 and inner cap 10. In the inner cap there is a chamber 20 having an opening 21 at its lower end and vent openings 22 at its upper end. Inside the chamber is a spring loaded pressure release valve 24. The steam cap further includes a pressure indicator 4 which is typically in the form of a coloured button.
Patent NZ-523630-A (NZ)
Title: Molecular control of transgene segregation and its escape by a recoverable block of function (RBF) system
Inventor: KUVSHINOV VIKTOR
IPC: C12N15/82
Filed: 2001-07-16
Abstract: A method and a complex of DNA constructs for providing an increased level of control of transgene segregation in non-human Sexually Reproducing Multicellular Organisms (SRMOs), which are prone to out-crossing with their wild-type or cultivated relatives. The method and constructs allow the farmer to reuse the transgenic crop without risk. The recoverable block of function (RBF) system comprises one or more Transgenes of Interest (TGIs) encoding desired gene products, one or more Blocking Constructs (BC), and one or more user-controlled means for recovering the blocked functions. The BC has the capacity of blocking at least one function essential for the survival and/or reproduction of the SRMO. Preferably more than one BC flanking the TGIs are used. The BC may be located in close proximity to the TGI, preferably in an intron or flanking the TGIs. The blocked function is recoverable by user-controlled interventions preferably applicable under confined conditions. The intervention is combined with one or more Recovering Constructs (RC). Different types of RBF systems are disclosed. The Double and Triple and Segregating RBF systems and intron-inserted BC are the preferred embodiments.
Patent NZ-523672-A (NZ)
Title: myostatin and GDF-8 proteins and methods of using same
Inventor: LEE SE-JIN
IPC: A23L15/00
Filed: 2001-07-26
Abstract: A substantially purified myostatin prodomain peptide has the amino acid residues from about 20 to 262 of a promyostatin polypeptide. The peptide has myostatin signal transduction inhibitory activity, myostatin binding activity and/or promyostatin binding activity. The peptide is produced by the cleavage of promyostatin polypeptide at a proteolytic cleavage site comprising the amino acid sequence Arg-Xaa-Xaa-Arg. Also described is a mutant promyostatin polypeptide comprising a mutation which disrupts proteolytic cleavage at the proteolytic cleavage site comprising the amino acid sequence Arg-Xaa-Xaa-Arg. Also described are antibodies, non-human transgenic organisms, and methods of identifying a functional peptide portion of a promyostatin prodomain.
Patent NZ-527166-A (NZ)
Title: A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge
Inventor: SCHAUFLER ALFRED
IPC: A61L24/08
Filed: 2002-01-25
Abstract: A method of preparing a collagen sponge comprises preparing a collagen gel and mixing air into the gel so as to obtain a collagen. Drying the foam to obtain a dry block of collagen sponge having a three-dimensional structure with stacked chambers which are separated and substantially totally enclosed by walls of collagen material, and then isolating from the block of collagen sponge, parts of sponge with a chamber diameter of more than 0.75 mm and less than 4 mm or parts or with an average chamber diagonal dimension of at most 3mm. Elongated collagen sponges produced by the method are also described. The sponges can be used for closing wounds or reestablishing walls in a mammalian gastrointestinal funnel or trachea system.
Patent NZ-538725-A (NZ)
Title: Combination inflation and relief valve
Inventor: ROGIER STEPHEN J
IPC: F16K15/20
Filed: 2003-09-15
Abstract: A combination inflation and relief valve having an inflation gasket mounted on a reciprocating stem head that separates from a valve seat of a valve body against the force of an inflation spring upon inflation and having a relief gasket mounted on a reciprocating push disk that separates from the stem head against the force of a relief spring to allow excess internal pressure to vent through relief holes.
Patent NZ-541023-A (NZ)
Title: Backlighting system for display screen
Inventor: EMSLIE JAMES STEPHEN
Filed: 2003-05-21
Abstract: A direct backlighting system for a display apparatus for particular use in multi-layer displays (MLDs) using LCD display screens is disclosed. The system controls the distribution of power to a light source 5 positioned behind the display apparatus. The electronic componentry of the system is mounted on first and second substrates 10, 14 and through electrical connectors 13 is directly electrically and physically connected to the light source. (62) Divided Out of 526028
Patent NZ-546158-A (NZ)
Title: Bicyclic imino acid derivatives used as inhibitors of matrix-metalloproteinases
Inventor: SCHUDOK MANFRED
IPC: C07D405/12
Filed: 2004-09-14
Abstract: Disclosed is a bicyclic imino acid compound of formula I and/or all the stereoisomeric forms of the compound of the formula I and/or mixtures of these forms in any ratio, and/or a physiologically tolerated salt of the compound of the formula I, wherein the substituents are disclosed within the specification. Also disclosed is the use of the above compound for producing a pharmaceutical for the prophylaxis and therapy of degenerative joint diseases, diseases of the connective tissue, periodontal diseases, wound healing disturbances and chronic diseases of the locomotory apparatus, myalgias, disturbances of bone metabolism, for the treatment of ulceration, atherosclerosis and stenoses, for the treatment of inflammations, cancer diseases, tumor metastases formation, cachexia, anorexia, heart failure and septic shock, or for the prophylaxis of myocardial and cerebral infections.
Patent NZ-549143-A (NZ)
Title: Feed material processing apparatus and methods utilizing a single vertical rotor
Inventor: MORRISON MICHAEL JOSEPH
IPC: B01F27/94
Filed: 2005-01-14
Abstract: A feed material processing apparatus 1 comprises a substantially cylindrical chamber 8 with an inlet 4 to the upper region of the chamber 8, an outlet 5 from a lower region of the chamber 8 and a single vertical rotor 3 with a substantially cylindrical cross- section. The rotor 3, which is driven by a rotation drive 11, rotates at speeds of between 200 to 1200 km/hr. The circulatory flow of feed material and/or gas within the chamber 8 is promoted by at least one vertically oriented feature or row of features 13 located laterally on the rotor 3.
Patent NZ-551345-A (NZ)
Title: Super-enhanced, adjustably buoyant floating island
Inventor: KANIA BRUCE G
IPC: A01G31/06
Filed: 2005-04-20
Abstract: A floating island comprising one or more layers, wherein at least one of the layers is comprised of water-permeable, nonwoven mesh material and buoyant nodules, and wherein the buoyant nodules are integral with the mesh material.
Patent NZ-554477-A (NZ)
Title: Compounds that modulate PPAR activity and methods for their preparation
Inventor: FILZEN GARY FREDERICK
IPC: C07D213/32
Filed: 2003-03-24
Abstract: Disclosed are compounds of formula (I) that modulate Peroxisome Proliferator Activation Receptor (PPAR) activity. Also disclosed are pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable compositions comprising the compounds or their salts, and their use as therapeutic agents for treating or preventing disipidemia, hypercholesteremia, obesity, eating disorders, hyperglycemia, atherosclerosis, hypertriglyceridemia, hyperinsulinemia and diabetes in a mammal as well as suppressing appetite and modulating leptin levels in a mammal. Furthermore, the compounds of the present disclosure are also useful in treating a patient exhibiting glucose disorders associated with circulating glucocorticoids, growth hormone, catecholamines, glucagons, or parathyroid hormone.
Patent NZ-566325-A (NZ)
Title: Chemical cleaning agent and process for cleaning filtration membranes
Inventor: MULLER HEINZ-JOACHIM
IPC: B01D65/06
Filed: 2006-09-27
Abstract: Disclosed is a method of cleaning a membrane comprising contacting the membrane with an aqueous solution comprising a monopersulfate anion, and a buffer, wherein the pH range of said aqueous solution is from 1.5 to 3, wherein the membrane is a porous polymeric ultrafiltration or microfiltration membrane, wherein the solution comprising monopersulfate anions is fed into a feed side of the membrane and the membrane is allowed to stand and soak in the solution.
Patent NZ-570207-A (NZ)
Title: Wetsuit with phase change material particles in clusters with spaces between adjacent clusters forming grid
Inventor: O'HARA TETSUYA
IPC: A41D13/02
Filed: 2007-02-02
Abstract: A wetsuit comprises an outer layer 12 and an inner layer 14 adjacent to the outer layer 12. The inner layer 14 comprises a plurality of fibers 16 disposed on a layer of fabric and configured in a plurality of clusters 18 to define a plurality of interconnected channels 20 between the clusters 18. At least a portion of each channel 20 is defined by a first channel wall comprising the fibers at an edge of a cluster 18, a second channel wall opposed to the first channel wall, the second channel wall comprising fibers at an edge of an adjacent cluster, and a channel bottom defined by the layer of fabric. Each channel 20 is wider than a space between adjacent fibers in each cluster 18.